Silvia Peola

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Roberto Piva, Bruce Ruggeri, Michael Williams et al. · Blood · 2007 · 252 citations · Full text

Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose Chemotherapy

Massimo Massaia, Paolo Borrione, Silvano Battaglio et al. · Blood · 1999 · 150 citations

Effector γδ T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma

Sara Mariani, Michela Muraro, Francesca Pantaleoni et al. · Leukemia · 2005 · 123 citations

Hematological Malignancy, Zoledronic Acid, Cancer Immunosurveillance +9

Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between Vγ9Vδ2 T Cells, αβ CD8+ T Cells, Regulatory T Cells, and Dendritic Cells

Barbara Castella, Chiara Riganti, Francesca Fiore et al. · The Journal of Immunology · 2011 · 74 citations

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells

Marta Coscia, Francesca Pantaleoni, Chiara Riganti et al. · Leukemia · 2011 · 61 citations · Full text

Hematological Malignancy, Spontaneous Apoptosis, Environmental Prosurvival Signals +10